These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29937206)

  • 1. A risk-based approach to development of ultrasound-based high-dose-rate prostate brachytherapy quality management.
    Poder J; Brown R; Howie A; Yuen J; Ralston A; Schreiber K; Bece A; Bucci J
    Brachytherapy; 2018; 17(5):788-793. PubMed ID: 29937206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure modes and effects analysis for ocular brachytherapy.
    Lee YC; Kim Y; Huynh JW; Hamilton RJ
    Brachytherapy; 2017; 16(6):1265-1279. PubMed ID: 28827007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monte Carlo study on the feasibility of real-time in vivo source tracking during ultrasound based HDR prostate brachytherapy treatments.
    Poder J; Cutajar D; Guatelli S; Petasecca M; Howie A; Bucci J; Carrara M; Rosenfeld A
    Phys Med; 2019 Mar; 59():30-36. PubMed ID: 30928063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAPM Task Group 128: quality assurance tests for prostate brachytherapy ultrasound systems.
    Pfeiffer D; Sutlief S; Feng W; Pierce HM; Kofler J
    Med Phys; 2008 Dec; 35(12):5471-89. PubMed ID: 19175107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BrachyView, a novel inbody imaging system for HDR prostate brachytherapy: design and Monte Carlo feasibility study.
    Safavi-Naeini M; Han Z; Cutajar D; Guatelli S; Petasecca M; Lerch ML; Franklin DR; Jakubek J; Pospisil S; Bucci J; Zaider M; Rosenfeld AB
    Med Phys; 2013 Jul; 40(7):071715. PubMed ID: 23822419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
    Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
    Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate.
    Bharat S; Kung C; Dehghan E; Ravi A; Venugopal N; Bonillas A; Stanton D; Kruecker J
    Brachytherapy; 2014; 13(6):640-50. PubMed ID: 24929641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy.
    Mayadev J; Dieterich S; Harse R; Lentz S; Mathai M; Boddu S; Kern M; Courquin J; Stern RL
    Brachytherapy; 2015; 14(6):866-75. PubMed ID: 26204807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study.
    Vigneault E; Mbodji K; Racine LG; Chevrette E; Lavallée MC; Martin AG; Després P; Beaulieu L
    Brachytherapy; 2016; 15(6):746-751. PubMed ID: 27743955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional transrectal ultrasound guided high-dose-rate prostate brachytherapy: A comparison of needle segmentation accuracy with two-dimensional image guidance.
    Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Montreuil J; D'Souza D; Fenster A; Wong E
    Brachytherapy; 2016; 15(2):231-9. PubMed ID: 26832673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
    White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results.
    Zamboglou N; Tselis N; Baltas D; Buhleier T; Martin T; Milickovic N; Papaioannou S; Ackermann H; Tunn UW
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):672-8. PubMed ID: 22929859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical implementation of quality improvement for high-dose-rate brachytherapy.
    Schubert L; Liu A; Gan G; Amini A; Hutchison R; Ernest J; Thornton D; Stoehr S; Hinman B; Stuhr K; Westerly D; Schefter T; Fisher C
    Pract Radiat Oncol; 2016; 6(1):34-43. PubMed ID: 26577008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance of HDR prostate plans: program implementation at a community hospital.
    Rush JB; Thomas MD
    Med Dosim; 2005; 30(4):243-8. PubMed ID: 16275567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
    Rink A; Borg J; Simeonov A; O'Leary G; Helou J; Ménard C; Chung P; Jaffray DA; Berlin A
    Brachytherapy; 2018; 17(1):59-67. PubMed ID: 28764881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
    Frank SJ; Mourtada F; Crook J; Orio PF; Stock RG; Petereit DG; Rossi PJ; Cox BW; Tang C; Kudchadker RJ; Bruno T; Ma J; Sanders J; Keyes M
    Brachytherapy; 2020; 19(6):787-793. PubMed ID: 33132070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations.
    Nunez DA; Trager M; Beaudry J; Cohen GN; Dauer LT; Gorovets D; Hassan Rezaeian N; Kollmeier MA; Leong B; McCann P; Williamson M; Zelefsky MJ; Damato AL
    Brachytherapy; 2021; 20(5):1062-1069. PubMed ID: 34193362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.